Is your child currently experiencing moderately to severely active IBD flare-ups? Local Crohn’s disease clinical research is testing a potential new medication to see if it may reduce rectal bleeding, mouth sores, constant need to poop, weight loss, and/or joint pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the Crohn’s disease clinical research.
Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.
By joining the GI studies, your child may receive:
- Compensation for study-related time
- Reimbursement for study-related travel
- Study-related care from local doctors
- Study medication at no cost
Health insurance is not required to take part.
Enrollment is limited, so please respond now.
